Esomeprazole Tablets 40 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Esomeprazole Tablets 40 mg | Manufacturer
Product image for Esomeprazole Tablets 40 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Esomeprazole |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP / BP |
| Product Type | Tablet |
| Category | Gastrointestinal drugs – Acid Suppression |
| Subcategory | Acid Suppression |
| Active Ingredient | Esomeprazole |
| Strength | 40 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Gastrointestinal drugs – Acid Suppression |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Esomeprazole Tablets 40 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Symptomatic relief and healing of erosive gastroesophageal reflux disease (GERD). 2. Treatment of gastric ulcers, duodenal ulcers, and NSAID-associated mucosal injury. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Esomeprazole Tablets 40 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Esomeprazole Tablets 40 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Esomeprazole Tablets 40 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Esomeprazole Tablets 40 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally 30 to 60 minutes before morning meals (or as prescribed for antacids, after meals and at bedtime). Swallow whole with water; do not crush or chew enteric-coated tablets. | ||||||||||||||||||||||||
| Side Effects | Common: Headache, diarrhea, constipation, abdominal discomfort, nausea. Uncommon: Flatulence, dry mouth, dizziness, transient transaminase elevation. Rare: Hypomagnesemia, Clostridioides difficile-associated diarrhea, subacute cutaneous lupus. | ||||||||||||||||||||||||
| Warnings and Precautions | Masking Malignancy: Symptomatic relief does not preclude presence of gastric malignancy; perform diagnostic workup if alarm symptoms exist. Long-Term Bone Density: Extended chronic use may slightly elevate risk of osteoporosis-related fractures; ensure adequate calcium and vitamin D intake. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Esomeprazole or substituted benzimidazoles / antacids. 2. Severe electrolyte imbalances (for magnesium/aluminum antacids in renal failure). 3. Concurrent administration with rilpivirine-containing products. | ||||||||||||||||||||||||
| Drug Interactions | 1. pH-Dependent Bioavailability Drugs (Ketoconazole, Itraconazole, Iron Salts): Reduced absorption due to elevated gastric pH. 2. Clopidogrel: Potential attenuation of antiplatelet activation by certain proton pump inhibitors. 3. Digoxin & Methotrexate: Elevated serum concentrations requiring dosage monitoring. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Esomeprazole Tablets 40 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Esomeprazole Tablets 40 mg? | The source specification is IP / BP; confirm the required standard before contracting. |
| What quality tests are applicable for Esomeprazole Tablets 40 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Esomeprazole Tablets 40 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Esomeprazole Tablets 40 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Esomeprazole Tablets 20 mg ExporterView product →
✚
Esomeprazole Tablets 20 mg ManufacturerView product →
✚
Esomeprazole Tablets 20 mg SupplierView product →
✚
Esomeprazole Tablets 40 mg ExporterView product →
✚
Esomeprazole Tablets 40 mg SupplierView product →
✚
Cimetidine Tablets USP 200 mg ExporterView product →
✚
Cimetidine Tablets USP 200 mg ManufacturerView product →
✚
Cimetidine Tablets USP 200 mg SupplierView product →
✚
Cimetidine Tablets USP 400 mg ExporterView product →
✚
Cimetidine Tablets USP 400 mg ManufacturerView product →
✚
Cimetidine Tablets USP 400 mg SupplierView product →
✚
Famotidine Tablets USP 20 mg ExporterView product →
